Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer.

Dong H, Hu J, Zou K, Ye M, Chen Y, Wu C, Chen X, Han M

Open source

DOI
10.1186/s12943-018-0931-9
Published
2019 Jan 8
Container
Molecular cancer
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 4/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12943-018-0931-9,
  title = {Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer.},
  author = {Dong H and Hu J and Zou K and Ye M and Chen Y and Wu C and Chen X and Han M},
  year = {2019},
  journal = {Molecular cancer},
  doi = {10.1186/s12943-018-0931-9},
  url = {https://doi.org/10.1186/s12943-018-0931-9}
}

RIS

TY  - JOUR
TI  - Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer.
AU  - Dong H
AU  - Hu J
AU  - Zou K
AU  - Ye M
AU  - Chen Y
AU  - Wu C
AU  - Chen X
AU  - Han M
PY  - 2019
JO  - Molecular cancer
DO  - 10.1186/s12943-018-0931-9
UR  - https://doi.org/10.1186/s12943-018-0931-9
ER  - 

APA

H, D., J, H., K, Z., M, Y., Y, C., C, W., X, C., & M, H. (2019). Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer.. Molecular cancer. https://doi.org/10.1186/s12943-018-0931-9

Source records